StoryFunding
SetPoint Medical raises $140M in Series C and D funding co-led by Elevage and Ally Bridge
SetPoint closed a combined Series C and D round of $140M (comprising $25M Series C and $115M Series D), co-led by Elevage Medical Technologies and Ally Bridge Group. The funds will support market launch in select U.S. centers in 2025 and broader national expansion in 2026, along with development of the SetPoint System for other autoimmune indications.